Fanconi Anaemia [FA] is a chromosomal instability disorder characterised by cellular sensitivity to DNA interstrand crosslinking [ICL] agents and a high risk of cancer. Six of the eight proteins encoded by the known FA genes form a nuclear complex which is required for the mono-ubiquitination of the FANCD2 protein. FANCD2 complexes and co-localises with BRCA1, but its presumptive role in DNA repair has not yet been clearly defined. We used yeast two hybrid analysis to test for interaction between FANCD2 and 10 proteins involved in homologous recombination repair. FANCD2 did not interact with RAD51, the five RAD51 paralogs, RAD52, RAD54 or DMC1. However, it bound to a highly conserved C-terminal site in BRCA2 that also binds FANCG/XRCC9. FANCD2 and BRCA2 can be co-immunoprecipitated from cell extracts of both human and Chinese hamster wild-type cells, thus confirming that the interaction occurs in vivo . Formation of nuclear foci of FANCD2 was normal in the BRCA2 mutant CAPAN-1 cells, which indicates that the recruitment of FANCD2 to sites of DNA-repair is independent of wildtype BRCA2 function. FANCD2 co-localised with RAD51 in foci following treatment with mitomycin C or hydroxyurea, and co-localised very tightly with PCNA after treatment with hydroxyurea. These findings suggest that FANCD2 may have a role in the cellular response to stalled replication forks or in the repair of replication-associated double-strand breaks, irrespective of the type of primary DNA lesion.
Introduction
Fanconi anaemia is an autosomal recessive genetic disorder characterised by progressive bone marrow failure, multiple congenital abnormalities and an increased risk of cancer.
The cellular phenotype is characterised by chromosomal instability and hypersensitivity to DNA interstrand crosslinking [ICL] agents such as mitomycin C [MMC] and cisplatin.
Currently, at least eleven complementation groups are known to exist [FA-A, B, C, D1, D2, E, F, G, I, J, L] (1, 2), and the genes for all of these groups except FA-B, FA-I and FA-J have been identified (3) (4) (5) (6) (7) (8) (9) (10) (11) . The FANCA, FANCC, FANCE, FANCF, FANCG and FANCL proteins have been shown to form a nuclear multiprotein complex, known as the FA core complex, which is required for the monoubiquitination of the FANCD2 protein (12) (13) (14) (15) (16) (17) (18) . How the modified form of FANCD2 contributes to DNA repair is not yet clear.
Recent studies have suggested a broader role for this protein in homologous recombination and double-strand break [DSB] repair [reviewed in D'Andrea and Grompe (19) ]. In particular, FANCD2 has been shown to co-immunoprecipitate with BRCA1 and NBS1, and to co-localise with these two proteins in DNA damage-induced nuclear foci (18, 20) . Also, FANCD2 is phosphorylated in vivo in an ATM-dependent manner following ionising radiation (21) , and chromosome pairing during the pachytene stage of meiosis is impaired in FANCD2 -/-mice (22) . Finally, whereas FANCD2 is activated relatively slowly after treatment with ICLs, activation is rapid in response to ionising radiation, and occurs only in S-phase after DSBs have formed (23) . also failed to interact with BRCA2 [ Fig. 1C ], confirming the importance of the Nterminus of FANCD2 for this interaction. This region is also involved in binding FANCE (26) , so the binding sites for FANCE and BRCA2 may overlap.
FANCD2 co-immunoprecipitates with BRCA2
The FANCD2/BRCA2 interaction observed in the yeast two hybrid system was further investigated by testing for co-immunoprecipitation of the endogenous proteins in extracts from mammalian cells. Cells were treated with MMC to induce DNA damage at a concentration (20nM), which allows >90% survival of wildtype mammalian cells in clonogenic assays (27) . BRCA2 was immunoprecipitated with FANCD2 using a 
BRCA2 is not required to recruit FANCD2 into foci
CAPAN-1 cells express only a single allele of the BRCA2 gene which is itself truncated within BRC7 of the BRCA2 protein (28) . BRCA2 in this cell line thus lacks the FANCD2 binding site as determined by our yeast two hybrid analysis. In order to determine whether FANCD2 binding to BRCA2 is required for the formation of FANCD2 foci, we treated CAPAN -1 cells with MMC and analysed the formation of FANCD2 foci. FANCD2 focus formation in these cells was found to be normal [Fig.   3A ]; the number of cells displayin g >5 FANCD2 foci was 13% before MMC treatment and 40% after MMC treatment, which is very similar to that seen in HeLa cells [ Table 1 ].
FANCD2 co-localises with RAD51 and PCNA following DNA damage
A major role of BRCA2 is thought to be in controlling the activity of the RAD51 recombinase (29-31) with which it interacts directly (32, 33) . In keeping with this idea, the formation of DNA damage-induced RAD51 foci has been shown to be critically dependent on BRCA2 (34) . In order to determine whether FANCD2 and RAD51 are involved in the same DNA damage-response pathway, we tested for their co-localisation following treatment with MMC in HeLa cells using confocal immunofluorescence microscopy. HeLa cells were treated with 50ng/ml MMC and stained for endogenous Table 1 ], suggesting that FANCD2 and RAD51 complexes co-operate in mounting a cellular response to DNA damage with ICL agents.
In order to determine whether FANCD2 might have a more general role in the repair process, rather than one limited specifically to the repair of ICLs, we tested for its ability to co-localise with RAD51 following treatment with the replication block inducing agent, hydroxyurea [HU] . Replication stalling by HU treatment is thought to result in replication fork collapse, which may lead to the formation of a double-strand break (36) .
HeLa cells were treated with 3mM HU and stained for endogenous FANCD2 and These observations suggested that FANCD2 could have a role either in the cellular response to stalled replication forks, or in the repair of DNA damage which is encountered following stalled replication. We tested this idea by looking for colocalisation of FANCD2 with PCNA foci which can be used to mark sites of DNA replication and repair (37) . There was little co-localisation of FANCD2 and PCNA foci before HU treatment. However, HU treatment caused a striking increase in the level of co-localisation of FANCD2 and PCNA [ Fig. 3C and Table 2 ]. Indeed, whereas the level of co-localisation between FANCD2 and RAD51 even after MMC and HU treatment was only partial, FANCD2 and PCNA co-localisation was in excess of 90% in more than 90% of cells displaying foci following HU treatment [ Fig. 3C and Table 2 ].
Discussion
In this study we demonstrate a direct interaction between the FANCD2 and BRCA2
proteins. The interaction mapped to part of the highly conserved BLAT domain in BRCA2 which has also been shown to bind FANCG/XRCC9 (25) . Very recently an FA-D1 patient-derived missense mutation in BRCA2 [L2510P] has also been identified in this region (38) . The fact that FANCD2 can interact with BRCA2 when expressed in the yeast two hybrid system indicates that mono -ubiquitination of FANCD2 is not required for binding of the two proteins. However, recruitment of FANCD2 into nuclear foci has been shown to be dependent on its ubiquitination (18) and this is consistent with the proposed role of mono-ubiquitination in protein trafficking (39) . Our observation that FANCD2 and BRCA2 fail to co-immunoprecipitate in several FA-G cell lines [ Fig. 2] that do not express monoubiquitinated FANCD2 (18, 27) suggests that it may be the ubiquitinated form that interacts with BRCA2 in vivo . However, it is also possible that FANCG, which itself interacts directly with BRCA2, may facilitate the FANCD2/BRCA2 interaction. BRCA2 does not appear to be required for the recruitment of FANCD2 in nuclear foci, since this process is undisturbed in CAPAN-1 cells, but it does require BRCA1 (18, 40) .
In this study we also show that FANCD2 co-localises with nuclear foci of RAD51 in response to various forms of DNA damage such as MMC and the replication blocking agent hydroxyurea. DNA damage-induced RAD51 foci have been proposed to be sites where double-strand break [DSB] repair is occurring by homologous recombination (41) .
It has previously been suggested that the repair of ICLs may occur via the formation of a DSB intermediate during replication (42, 43) , and HU-induced replication fork blockage may also result in the formation of a DSB (36) . It is therefore possible that FANCD2 localises to sites of DSBs, irrespective of the type of primary DNA lesion, to co-operate with BRCA2 and RAD51 in their repair.
Our observation that FANCD2 co-localises very tightly with PCNA following treatment with HU is consistent either with a role for FANCD2 in the cellular response to stalled replication forks or in the repair of DSBs that arise subsequently. The involvement of BRCA2 in replication-associated DNA repair has also been suggested by the fact that it is expressed mainly in S-phase (44) , and co-localises with PCNA foci following HU treatment (45) . Recently, it has been proposed that BRCA2 stabilises DNA structures at stalled forks, and that the chromosomal instability associated with a deficiency of BRCA2 is a consequence of an inability to respond to stalled replication (46) . The direct interaction of FANCD2 with BRCA2 and its tight co-localisation wit h PCNA after HU treatment suggests that it may also be a part of this process. The interaction does not require exogenous DNA damage, since we found that FANCD2 and BRCA2 could be coimmunoprecipitated in untreated cells. This is consistent with our observation of substantial co-localisation of FANCD2 with RAD51 even in untreated cells, which are likely to be in S-phase (35) . It is possible that endogenous compounds such as reactive oxygen species may induce DNA damage which generates stalled replication fo rks (47), thereby promoting the interaction of FANCD2 with the BRCA2-RAD51 complex. Also, stalling of replication forks occurs commonly in normally dividing cells (48) .
The observation that FANCG and FANCD2 bind to the same site in BRCA2
suggests that these three proteins may co-operate in the repair process. Chicken DT40 (24) ]. The interactions of FANCG and FANCD2 with BRCA2 may lead to conformational changes important for RAD51-ssDNA interactions. For example, a structure has recently been proposed for BRCA2-RAD51 interaction in which the BRC repeats of BRCA2 wrap around RAD51 ring structures, which brings N-terminal and Cterminal regions of BRCA2 into close apposition (50) . It is proposed that the complex is recruited to a DSB, where the BRC repeats disassemble the ring, and RAD51 monomers are loaded onto ssDNA. Since we have previously shown that FANCG binds to both the N-terminal and C-terminal regions of BRCA2, it is possible that FANCG binds both these regions of BRCA2 simultaneously, thus stabilising the structure until the correct signal is received at the site of a DSB for unloading of RAD51. FANCD2 could be a part of this signal by replacing FANCG at the same C-terminal region of BRCA2. Although we currently lack an understanding of the precise function of the FA pathway, these studies indicate that at least some of the FA proteins are directly associated with key elements of homologous recombination repair such as the BRCA2-RAD51 complex.
Material and Methods

Plasmid Constructs
Full length cDNAs for human RAD51, XRCC2, XRCC3, RAD51B, RAD51C, RAD51D, fusions with either the GAL4 bind ing domain [BD] or the GAL4 activation domain [AD] and were verified by sequencing. FANCD2 and BRCA2 constructs have been described elsewhere (51, 52) . Constructs contained full length cDNAs unless otherwise stated.
Yeast-two -hybrid analysis
The MATCHMAKER Two Hybrid System 3 [Clontech] was used for yeast two hybrid analysis according to the manufacturer's instructions and as described previously (15, 53) . Briefly, GAL4 activation domain and GAL4 binding domain constructs were either sequentially transformed into AH109 yeast cells and subjected to selection on [-trp-leuhis-ade] medium, or transformed separately into AH109 and Y187 yeast strains and mating cultures plated onto selection medium. Transformations were performed using a PEG/ssDNA/lithium acetate procedure. Colonies were then transferred onto filters and tested for ß-galactosidase expression with X-gal. Each experiment was performed at least in triplicate, and constructs were tested for autoactivation and against a series of control plasmids. 5mM 3-AT was added to the media to suppress slight autoactivation of some constructs. A semiquantitative test of interaction strength based on the extent of reporter gene activation was carried out as previously described, where reporter gene activation =
[n x C/t x lnT], where n = number of blue colonies, C = intensity of blue colour, t = time of colony growth prior to LacZ expression testing and T = time taken for colour development.
Co-immunoprecipitation and immunoblotting
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Wild -type human cell lines HeLa and CRL-1583 and hamster cell lines AA8 and NM3
were cultured in DMEM with 10% FCS as previously described (54) . CRL-1583 is a human SV40-transformed placental cell line (55) . AA8 is a Chinese hamster ovary cell line and NM3 is a FANCG mutant derived from AA8 that has a frameshift mutation in exon 3 which causes premature truncation of FANCG (27, 56) . FA-G cell lines . After centrifugation at 4°C, undiluted anti-FANCD2 was added to the supernatant and mixed gently for 2 hours at 4°C. Antibodyantige n complexes were then purified using the recommended procedure and the resulting 25 µl sample loaded onto an SDS-PAGE gel. Electrophoresis and transfer of proteins onto nitrocellulose membrane was as previously described (27) 
Immunofluorescence and microscopy
HeLa cells used for all immunofluorescence experiments were cultured at 37°C at 5% 
